Elsevier

Advances in Nutrition

Volume 6, Issue 4, July 2015, Pages 461-473
Advances in Nutrition

Dietary Advanced Glycation End Products and Their Role in Health and Disease

https://doi.org/10.3945/an.115.008433Get rights and content
Under a Creative Commons license
open archive

ABSTRACT

Over the past 2 decades there has been increasing evidence supporting an important contribution from food-derived advanced glycation end products (AGEs) to the body pool of AGEs and therefore increased oxidative stress and inflammation, processes that play a major role in the causation of chronic diseases. A 3-d symposium (1st Latin American Symposium of AGEs) to discuss this subject took place in Guanajuato, Mexico, on 1–3 October 2014 with the participation of researchers from several countries. This review is a summary of the different presentations and subjects discussed, and it is divided into 4 sections. The first section deals with current general knowledge about AGEs. The second section dwells on mechanisms of action of AGEs, with special emphasis on the receptor for advanced glycation end products and the potential role of AGEs in neurodegenerative diseases. The third section discusses different approaches to decrease the AGE burden. The last section discusses current methodologic problems with measurement of AGEs in different samples. The subject under discussion is complex and extensive and cannot be completely covered in a short review. Therefore, some areas of interest have been left out because of space. However, we hope this review illustrates currently known facts about dietary AGEs as well as pointing out areas that require further research.

nutrition
oxidative stress
inflammation
insulin resistance
RAGE
nutraceutical

Abbreviations

ACE
angiotensin-converting enzyme
AGE
advanced glycation end product
AQC
6-aminoquinonyl-N-hydroxysuccinimidyl-carbamate
CKD
chronic kidney disease
esRAGE
endogenous secretory RAGE
OPA
ortho-phthalaldehyde
OS
oxidative stress
RAGE
receptor for advanced glycation end products
sRAGE
soluble receptor for advanced glycation end products

Cited by (0)

The authors reported no funding received for this study.

Author disclosures: J Uribarri, MD del Castillo, MP de la Maza, R Filip, A Gugliucci, C Luevano-Contreras, MH Macías-Cervantes, DH Markowicz Bantos, A Medrano, T Menini, M Portero-Otin, A Rojas, GR Sampaio, Kaz Wrobel, Kat Wrobel, and ME Garay-Sevilla, no conflicts of interest.